Skip to main content
. 2022 Sep 21;2022:9897464. doi: 10.34133/2022/9897464

Figure 8.

Figure 8

Schematic illustration of combined treatment strategy for delivering ROS inducers to tumor cells. (a) Schematic illustration of tumor treatment strategy combined with SDT and CDT. Reprinted with permission from Lin et al. [139] Copyright 2020, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. (b) Schematic illustration of tumor treatment strategy combined with PTT and CDT. Reprinted with permission from Hu et al. [140] Copyright 2020, Nature Publishing Group. (c) Schematic illustration of nanolongan with multiple conversions and the corresponding anticancer mechanism. Reprinted with permission from Bao et al. [141] Copyright 2019, American Chemical Society. (d) Schematic illustration of a biomimetic magnetosome for ferroptosis/immunomodulation synergism in cancer. Reprinted with permission from Zhang et al. [142] Copyright 2019, American Chemical Society.